Karine Breckpot

17PUBLICATIONS
52CO-AUTHORS
Radiation therapyMolecular targetsMedical molecular engineering of nucleic acids and proteinsGene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 01, 2025
Immune modulation following α and β<sup>-</sup> radionuclide therapy targeting fibroblast activation protein-α in a preclinical tumor model.

Hannelore Ceuppens, Kirsten De Ridder, Thomas Ertveldt

|Jun 19, 2024
Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties.

Heleen Hanssens, Fien Meeus, Emma L Gesquiere

|Jan 22, 2024
Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA).

Ignasi Esteban, Carmen Pastor-Quiñones, Lorena Usero

|May 18, 2022
RNA in Cancer Immunotherapy: Unlocking the Potential of the Immune System.

Wout De Mey, Arthur Esprit, Kris Thielemans

|May 14, 2022
Oncolytic Herpes Simplex Virus Type 1 Induces Immunogenic Cell Death Resulting in Maturation of BDCA-1<sup>+</sup> Myeloid Dendritic Cells.

Philipp Kalus, Jolien De Munck, Sarah Vanbellingen

|May 02, 2022
Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177-Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma Model.

Thomas Ertveldt, Lien De Beck, Kirsten De Ridder

Pageof 3

Frequent Collaborators

8 joint publications

Nick Devoogdt

7 joint publications

Quentin Lecocq

6 joint publications

Marleen Keyaerts

4 joint publications

Yannick De Vlaeminck